Second-quarter earnings more than doubled at US
health-care product maker Johnson & Johnson, the company said Monday.
Quarterly net income was 3.8 billion dollars, or 1.3 dollars a share. The New Jersey-based company attributed the higher earnings in part to the sale of its stake in Elan Corporation.
Revenue rose 8.5 per cent to 17.8 billion dollars year-on-year. Both earnings and revenue beat Wall Street's expectations, Bloomberg news reported.
Most Popular Stories
- Boehner Lashes Out Against Ted Cruz, Far Right
- Hawaii Official Who Release Obama Certificate Only Victim of Plane Crash
- Ted Cruz Coloring Book Selling Briskly
- Ford Plans New Cars, Jobs in 2014
- 'Rape Insurance' Bill Passes in Michigan
- Grizzly Bears Could Be Taken Off Endangered List
- Kim Jong Un's Uncle Executed
- Gold, Silver Slide on Prospects of Fed Exit
- Holiday Shopping Off to a Slow Start This Season
- Podesta Likely to Reject Keystone XL